Decreasing systemic inflammation may be the cure for everything according to AARP Chronic inflammation in the body may be the basis for disease. Nutritionists and other complementary health providers have known this for years. Modern medicine has been slow to adopt these facts until recently. The typical medical approach of a symptom and a drug has resulted in high healthcare costs, more side effects and poorer health as we age. Inflammation plays a role in everyone’s health, but it also plays a role in many chronic diseases that may be preventable by reducing the level of inflammation in the body. Too much inflammation can cause problems in the circulatory system, the heart and gut. Heart disease, many autoimmune diseases, and cancer may be preventable by treating inflammation. Cardiologists in Boston have reported on a clinical trial with more than 10,000 patients in 39 countries (mean age: 61) that tested to see if an anti-inflammatory drug could lower rates of heart disease. They discovered that it could. But they also found that the same drug, canakinumab, reduced lung cancer mortality more than 77 percent, and reports of gout and arthritis (conditions linked to inflammation) also fell. Big Pharma’s approach may be FDA approval for a new use for anti-inflammatory drugs that may have side effects, you can reduce inflammation naturally in your body without the side effects. Deflame is a pack that includes products recommended in Jeffery Seaman’s Deflame Diet which includes Ginger Omega 3’s Turmeric Whole-food Bioflavonoids Rosemary. A box of deflame which includes 30 vitamin packets if taken for a few months will markedly reduce inflammation in your body and it is available in our North Brunswick and Scotch Plains offices. Deflame is affordably priced at $60 per box. Learn more about chronic inflammation and its effects in this well written and researched AARP article. Could Decreasing Inflammation Be the Cure for Everything? Managing your body’s immune response is key to diseases of aging by Mike Zimmerman, AARP, November 1, 2019 It hardly sounds serious at all. An inconvenience, perhaps, like maybe a mild fever or a creaky joint. In the lexicon of aging and disease, there are far more worrisome words: cancer, heart disease, dementia, diabetes. But researchers have suspected for years that all of these health issues, and more, have at their heart one common trigger: low-grade inflammation. And now they may finally have proof. Cardiologists in Boston have reported on a clinical trial with more than 10,000 patients in 39 countries (mean age: 61) that tested to see if an anti-inflammatory drug could lower rates of heart disease. They discovered that it could. But they also found that the same drug, canakinumab, reduced lung cancer mortality more than 77 percent, and reports of gout and arthritis (conditions linked to inflammation) also fell. “Inflammation plays a role in everyone’s health,” says Dana DiRenzo, a rheumatologist and instructor of medicine at Johns Hopkins University School of Medicine in Baltimore. When inflammation levels increase, so does the risk of disease. But understanding inflammation can be tricky because, when you get a disease, inflammation levels naturally increase as your body fights the condition. Inflammation, in other words, is both good and bad. Read more